Skip to search formSkip to main contentSkip to account menu

Betaseron

Known as: Beta Seron, Beta-Seron 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
While cell therapy has been proposed as next-generation therapy to treat the diseased heart, current strategies display only… 
Highly Cited
2016
Highly Cited
2016
Objective: To assess outcomes for patients treated with interferon beta-1b immediately after clinically isolated syndrome (CIS… 
Review
2006
Review
2006
Interferon beta (IFNβ) preparations are the most frequently prescribed therapies for patients with relapsing multiple sclerosis… 
Highly Cited
2005
Highly Cited
2005
An open-label extension study of the phase III trial of intramuscular interferon beta-1a (IFNβ-1a-Avonex) was conducted to… 
Review
2001
Review
2001
We previously reported results of a 12 month prospective, non-randomized, open-label treatment trial of immunomodulatory therapy… 
Review
2001
Review
2001
A prospective, non-randomized, open-label treatment trial was performed in patients with relapsing-remitting multiple sclerosis… 
Highly Cited
1998
Highly Cited
1998
  • G. Williams, P. Witt
  • Journal of interferon & cytokine research : the…
  • 1998
  • Corpus ID: 45613220
The aim of this 1 week study was to compare the biologic effects induced by Betaseron and AVONEX using their approved dose, route… 
1997
1997
The recently reported decrease in beta interferon (IFNβ) efficacy induced by anti-IFNβ antibodies1 has prompted Berlex… 
1996
1996
Production of T helper 1 and T helper 2 cytokines was investigated in peripheral blood mononuclear cells (PBMCs) from multiple… 
1995
1995
A new method for purifying human interferon-beta SER17 from E. coli-derived inclusion bodies has been developed. This procedure…